The rationale for their implementation in this setting originates from the observation that CTLA-4, PD-1, and PDL-1 are overexpressed in the tumour microenvironment, on tumour cells, and T cells intermingled with neoplastic cells [4]. This evidence concerns the gene CD274 and neoplasm.